Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Amyloidosis × Dexamethasone × Clear all

Phase

Status

Sponsor Class

OTHER 16 INDUSTRY 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia 19 Lymphoma 15 Burkitt Lymphoma 8 Neoplasms, Plasma Cell 5 Hodgkin Disease 5 Recurrence 4 Leukemia, Biphenotypic, Acute 4 Immunoglobulin Light-chain Amyloidosis 4 Waldenstrom Macroglobulinemia 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Vomiting 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Seminoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1

Interventions

pomalidomide 1 isatuximab 1 Melphalan 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡